DE3882140D1 - Praenatales screening fuer downs-syndrom. - Google Patents
Praenatales screening fuer downs-syndrom.Info
- Publication number
- DE3882140D1 DE3882140D1 DE8888905972T DE3882140T DE3882140D1 DE 3882140 D1 DE3882140 D1 DE 3882140D1 DE 8888905972 T DE8888905972 T DE 8888905972T DE 3882140 T DE3882140 T DE 3882140T DE 3882140 D1 DE3882140 D1 DE 3882140D1
- Authority
- DE
- Germany
- Prior art keywords
- alpha
- praenatales
- syndrom
- fuer
- downs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/385—Congenital anomalies
- G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Holo Graphy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878716158A GB8716158D0 (en) | 1987-07-09 | 1987-07-09 | Antenatal screening for down's syndrome |
GB878724913A GB8724913D0 (en) | 1987-10-23 | 1987-10-23 | Antenatal screening for down's syndrome |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3882140D1 true DE3882140D1 (en) | 1993-08-05 |
DE3882140T2 DE3882140T2 (de) | 1993-12-23 |
Family
ID=26292455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE88905972T Expired - Lifetime DE3882140T2 (de) | 1987-07-09 | 1988-07-11 | Pränatales screening für downs-syndrom. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0362294B1 (de) |
JP (1) | JP2525474B2 (de) |
AT (1) | ATE91182T1 (de) |
DE (1) | DE3882140T2 (de) |
DK (1) | DK172477B1 (de) |
WO (1) | WO1989000696A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252489A (en) * | 1989-01-17 | 1993-10-12 | Macri James N | Down syndrome screening method utilizing dried blood samples |
US5258907A (en) * | 1989-01-17 | 1993-11-02 | Macri James N | Method and apparatus for detecting down syndrome by non-invasive maternal blood screening |
ATE252240T1 (de) * | 1989-01-17 | 2003-11-15 | Jn Macri Technologies Llc Inc | Einrichtung zum nachweis vom down syndrom durch nichtinvasive siebtestung des mütterlichen blutes |
US5324667A (en) * | 1989-01-17 | 1994-06-28 | Macri James N | Method for detecting down sydrown by non-invasive maternal blood screening |
GB9224965D0 (en) * | 1992-11-28 | 1993-01-20 | Kodak Ltd | Antenatal screening for chromosomal abnormalities |
GB9306354D0 (en) * | 1993-03-26 | 1993-05-19 | Kodak Ltd | Antenatal screening for chromosomal abnormalities |
US5583612A (en) * | 1994-07-14 | 1996-12-10 | Xerox Corporation | Flexible latch with relaxed engagement |
GB9315230D0 (en) * | 1993-07-22 | 1993-09-08 | Kodak Ltd | Antenatal screening for chromosomal abnormalities |
GB9416415D0 (en) * | 1994-08-13 | 1994-10-05 | Kodak Ltd | Antenatel screening for pregnacy abnormalities |
GB9606261D0 (en) * | 1996-03-25 | 1996-05-29 | Johnson & Johnson Clin Diag | Prenatal screening for fetal abnormalities |
KR100459271B1 (ko) * | 2002-04-26 | 2004-12-03 | 엘지.필립스 엘시디 주식회사 | 구리 단일막 또는 구리 몰리브덴막의 식각용액 및 그식각방법 |
WO2012049874A1 (ja) * | 2010-10-13 | 2012-04-19 | ヒューマン・メタボローム・テクノロジーズ株式会社 | 脂肪性肝疾患を診断するためのバイオマーカー、その測定方法、コンピュータプログラム、および、記憶媒体 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4454232A (en) * | 1982-06-07 | 1984-06-12 | Bio-Rad Laboratories, Inc. | Estriol assay |
GR850899B (de) * | 1984-04-12 | 1985-11-25 | Gen Hospital Corp | |
US4670401A (en) * | 1985-01-25 | 1987-06-02 | Monell Chemical Senses Center | Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators |
-
1988
- 1988-07-11 AT AT88905972T patent/ATE91182T1/de not_active IP Right Cessation
- 1988-07-11 EP EP88905972A patent/EP0362294B1/de not_active Expired - Lifetime
- 1988-07-11 JP JP63505897A patent/JP2525474B2/ja not_active Expired - Lifetime
- 1988-07-11 DE DE88905972T patent/DE3882140T2/de not_active Expired - Lifetime
- 1988-07-11 WO PCT/GB1988/000557 patent/WO1989000696A1/en active IP Right Grant
-
1989
- 1989-03-09 DK DK198901154A patent/DK172477B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0362294B1 (de) | 1993-06-30 |
WO1989000696A1 (en) | 1989-01-26 |
DK115489D0 (da) | 1989-03-09 |
DE3882140T2 (de) | 1993-12-23 |
JP2525474B2 (ja) | 1996-08-21 |
DK115489A (da) | 1989-05-09 |
ATE91182T1 (de) | 1993-07-15 |
EP0362294A1 (de) | 1990-04-11 |
JPH03502483A (ja) | 1991-06-06 |
DK172477B1 (da) | 1998-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3882140D1 (en) | Praenatales screening fuer downs-syndrom. | |
YAMAMOTO et al. | Longitudinal study or serum thyroid hormones, chorionic gonadotrophin and thyrotrophin during and after normal pregnancy | |
US7892774B2 (en) | Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor | |
Confino et al. | The predictive value of hCG β subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer: an international collaborative study | |
IL139302A (en) | Antenatal screening for down's syndrome | |
CA2264840A1 (en) | Prenatal screening for down's syndrome using hyperglycosylated gonadotropin | |
DK0409956T3 (da) | Downs syndrom-screeningmetode | |
Dumps et al. | Accuracy of single measurements of pregnancy-associated plasma protein-A, human chorionic gonadotropin and progesterone in the diagnosis of early pregnancy failure | |
DK0627082T4 (da) | Antenatal screening for kromosomale abnormaliteter | |
Andersen | Concentrations of free oestradiol and progesterone in human preovulatory follicular fluid | |
Jenkins et al. | The detrimental influence of functional ovarian cysts during in-vitro fertilization cycles | |
Houghton et al. | Relationship of maternal and fetal levels of human placental lactogen to the weight and sex of the fetus | |
AU2848795A (en) | Antenatal screening for pregnancy abnormalities | |
Johnson et al. | The role of trophoblast dysfunction in the aetiology of miscarriage | |
CN1085339C (zh) | 用于监测安全期避孕的方法及监测用试纸 | |
Chatzakis et al. | Dramatic increase in levels of placental protein 14 in amniotic fluid at 10–15 weeks' pregnancy | |
JP3440138B2 (ja) | 染色体異常について妊娠期間中にスクリーニングするための方法および装置 | |
Walker | Assessment of endocrine function by salivary steroids | |
Hui et al. | Amniotic fluid human chorionic gonadotrophin and alpha‐fetoprotein levels in pregnancies conceived after assisted reproduction | |
Gustafson et al. | Sex hormone-binding globulin, oestradiol-17β, progesterone and testosterone at stimulation and after embryo transfer during in-vitro fertilization | |
Wasant et al. | Normal values of second trimester maternal serum alpha fetoprotein in Thai pregnant women | |
Grudzinskas | Biochemical Screening for Down Syndrome | |
Grudzinskas | Biochemical screening for down syndrome: A workshop report | |
Grella et al. | What are the most suitable fetoplacental tests in the monitoring of the third trimester of pregnancy? | |
Wasley | Pregnancy testing. What will it be? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |